Cone Snail Venom Contains Pain-Relieving Peptides That Activate Cannabinoid Receptors Without Psychoactive Effects | Research

The takeaway

Peptides from Conus textile and C. miles venoms activated CB1 cannabinoid receptors and relieved chronic pain in animal models with mild to no psychoactive side effects — a potential source of safer alternatives to cannabis-based pain drugs.

Pain relief without the high
Cone snail peptides activated CB1 cannabinoid receptors and relieved chronic pain with mild to no psychoactive side effects — unlike THC which causes significant CNS effects

What the researchers found

C. textile and C. miles venom subfractions activated CB1 receptor internalization, reduced pain in formalin test and nerve injury model after intrathecal injection, and showed mild to no side effects in CB tetrad assessment. Active components confirmed as peptides.

Why it matters

Chronic pain treatment desperately needs alternatives to opioids and cannabis. Peptides that activate cannabinoid receptors without psychoactive effects could provide effective pain relief without the drawbacks of either drug class.

The numbers in context

C. textile and C. miles active; CB1 internalization; formalin phase 2 reduced; allodynia reduced; peptidergic; mild/no CB tetrad effects

How the study worked

Cell-based CB1 receptor internalization assays in HEK293 cells. HPLC fractionation of venom. Intrathecal injection in rodents. Formalin test (inflammatory pain) and peripheral nerve injury model (neuropathic pain). CB tetrad assessment for psychoactive side effects. Proteolytic enzyme treatment to confirm peptide nature.

Who was studied

Rats in formalin test and peripheral nerve injury pain models

What this study cannot tell us

Active peptides not yet fully purified or sequenced. Intrathecal delivery limits practical application. CB1/CB2 selectivity not fully characterized. Small animal models may not predict human responses. Manufacturing challenges for conotoxins.

How to read the evidence

Low-to-moderate evidence: cell-based and animal pain model data with side effect profiling, but active peptides not yet fully identified.

When this study was published

Published 2021. Conotoxin research continues to uncover new analgesic peptides with diverse mechanisms.

The bigger picture

Cone snail venom already yielded ziconotide for pain. Discovering CB receptor-active conotoxins adds another mechanism to the cone snail analgesic toolkit and represents a completely new approach to cannabinoid-based pain therapy — peptides instead of plant chemicals.

Questions still open

What are the specific peptide sequences responsible for CB1 activation?
Could these peptides be delivered systemically or must they remain spinal?
Would they provide pain relief in clinical chronic pain conditions?

Common questions

Can cone snail venom treat pain?

Cone snail venom already contains ziconotide (Prialt), an FDA-approved pain drug. This study found additional venom peptides that activate cannabinoid receptors — the same system targeted by cannabis — but without the psychoactive "high." These peptides reduced pain in animal models.

Are these peptides like marijuana?

They activate the same receptors (CB1) but through peptide molecules rather than THC. Importantly, they showed mild to no psychoactive side effects in animal testing — meaning they might provide cannabis-like pain relief without the mind-altering effects.

Read the original research

Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats.

Pharmacology, biochemistry, and behavior, 205, 173182

View on PubMed ↗Publisher’s paper ↗

Citation

Jergova, Stanislava; Perez, Cecilia; Imperial, Julita S; Gajavelli, Shyam; Jain, Aakangsha; Abin, Adam; Olivera, Baldomero M; Sagen, Jacqueline. (2021). Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats.. Pharmacology, biochemistry, and behavior, 205, 173182. https://doi.org/10.1016/j.pbb.2021.173182